Atlas Trials

Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer

Clinical trial NCT04103697 · UNKNOWN

Trial details

NCT number
NCT04103697
Sponsor
Blokhin's Russian Cancer Research Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Rectal Neoplasms MalignantRectum CarcinomaRectal Cancer
Start date
2019-08-01
Primary completion
2024-08-01
Enrollment
560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.